Vaxart (merged with Aviragen Therapeutics)'s Series B - II Round

Vaxart (merged with Aviragen Therapeutics) raised a round of funding on March 23, 2010.

Vaxart has developed a vaccine delivery system that greatly enhances the adaptive immune response to orally delivered antigens. The vaccine system provides a key stimulatory signal (double-stranded RN…

Articles about Vaxart (merged with Aviragen Therapeutics)'s Series B - II Round: